Kesler Norman & Wride’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
4,271
-642
-13% -$133K 0.16% 142
2026
Q1
$1.04M Buy
4,913
+11
+0.2% +$2.37K 0.18% 125
2025
Q4
$1.01M Buy
+4,902
New +$923K 0.17% 128
2025
Q3
Sell
-4,545
Closed -$763K 224
2025
Q2
$763K Buy
+4,545
New +$675K 0.14% 163

Other funds holding CAH

Kesler Norman & Wride's CAH Position: Q2 2026 in Review

Kesler Norman & Wride reduced its Cardinal Health (CAH) stake by 13% in Q2 2026, selling an estimated $133K and leaving 4,271 shares worth $1.01M. The position accounts for 0.16% of the portfolio, ranked #142.

Kesler Norman & Wride first reported a position in CAH in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.04M in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Kesler Norman & Wride held 4,271 shares of Cardinal Health worth $1.01M as of Q2 2026.
  • Kesler Norman & Wride sold 642 Cardinal Health shares in Q2 2026, an estimated $133K.
  • Cardinal Health made up 0.16% of Kesler Norman & Wride's portfolio in Q2 2026, its #142 holding.
  • Kesler Norman & Wride first reported a position in Cardinal Health in Q2 2025 and has held it in 4 quarters since.
  • Kesler Norman & Wride's Cardinal Health position peaked at $1.04M in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.